Search research articles
Contact Us
Filters
Showing results (161-170 of 212) with videos related to
Page
of 22
Sort By:
Journal of Viral Hepatitis
|
September 24, 2016
No detectable resistance to tenofovir disoproxil fumarate in HBeAg+ and HBeAg- patients with chronic hepatitis B after 8 years of treatment
Y Liu, A C Corsa, M Buti, et al.
Gut
|
September 27, 2007
Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C
T Asselah, I Bieche, S Narguet, et al.
Clinical and Experimental Immunology
|
November 1, 1995
CD4+/CD8+ ratio of liver-derived lymphocytes is related to viraemia and not to hepatitis C virus genotypes in chronic hepatitis C
B N Pham, M Martinot-Peignoux, J F Mosnier, et al.
Lancet (London, England)
|
November 10, 1998
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)
T Poynard, P Marcellin, S S Lee, et al.
Clinical and Experimental Rheumatology
|
January 1, 1991
Latent hepatitis B virus (HBV) infection in systemic necrotizing vasculitis
P Marcellin, Y Calmus, H Takahashi, et al.
Journal of Hepatology
|
March 1, 1992
Failure of acyclovir to enhance the antiviral effect of alpha lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B. A multi-centre randomized controlled trial
L Berk, S W Schalm, R A de Man, et al.
Hepatology (Baltimore, Md.)
|
October 27, 2001
Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA
M Martinot-Peignoux, N Boyer, D Cazals-Hatem, et al.
Transplantation
|
June 15, 1995
alpha-Interferon-induced rejection of a hepatitis C virus-infected liver allograft tolerated with a low dosage immunosuppressive regimen
A C Gadano, J F Mosnier, F Durand, et al.
Journal of Viral Hepatitis
|
January 11, 2008
Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin
K R Reddy, S Govindarajan, P Marcellin, et al.
Journal of Hepatology
|
March 9, 2000
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B
V Carreño, S Zeuzem, U Hopf, et al.
Page
of 22
Search research articles
Search
Showing results (161-170 of 212) with videos related to
Sort By:
Page
of 22
Journal of Viral Hepatitis
|
September 24, 2016
No detectable resistance to tenofovir disoproxil fumarate in HBeAg+ and HBeAg- patients with chronic hepatitis B after 8 years of treatment
Y Liu, A C Corsa, M Buti, et al.
Gut
|
September 27, 2007
Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C
T Asselah, I Bieche, S Narguet, et al.
Clinical and Experimental Immunology
|
November 1, 1995
CD4+/CD8+ ratio of liver-derived lymphocytes is related to viraemia and not to hepatitis C virus genotypes in chronic hepatitis C
B N Pham, M Martinot-Peignoux, J F Mosnier, et al.
Lancet (London, England)
|
November 10, 1998
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)
T Poynard, P Marcellin, S S Lee, et al.
Clinical and Experimental Rheumatology
|
January 1, 1991
Latent hepatitis B virus (HBV) infection in systemic necrotizing vasculitis
P Marcellin, Y Calmus, H Takahashi, et al.
Journal of Hepatology
|
March 1, 1992
Failure of acyclovir to enhance the antiviral effect of alpha lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B. A multi-centre randomized controlled trial
L Berk, S W Schalm, R A de Man, et al.
Hepatology (Baltimore, Md.)
|
October 27, 2001
Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA
M Martinot-Peignoux, N Boyer, D Cazals-Hatem, et al.
Transplantation
|
June 15, 1995
alpha-Interferon-induced rejection of a hepatitis C virus-infected liver allograft tolerated with a low dosage immunosuppressive regimen
A C Gadano, J F Mosnier, F Durand, et al.
Journal of Viral Hepatitis
|
January 11, 2008
Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin
K R Reddy, S Govindarajan, P Marcellin, et al.
Journal of Hepatology
|
March 9, 2000
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B
V Carreño, S Zeuzem, U Hopf, et al.
Page
of 22